Prediction of acute multiple sclerosis relapses by transcription levels of peripheral blood cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1755-8794
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Prediction of acute multiple sclerosis relapses by transcription levels of peripheral blood cells ; volume:2 ; number:1 ; day:22 ; month:7 ; year:2009 ; pages:1-14 ; date:12.2009
BMC medical genomics ; 2, Heft 1 (22.7.2009), 1-14, 12.2009
- Urheber
-
Gurevich, Michael
- Beteiligte Personen und Organisationen
-
Tuller, Tamir
Rubinstein, Udi
Or-Bach, Rotem
Achiron, Anat
SpringerLink (Online service)
- DOI
-
10.1186/1755-8794-2-46
- URN
-
urn:nbn:de:1111-201607224003
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gurevich, Michael
- Tuller, Tamir
- Rubinstein, Udi
- Or-Bach, Rotem
- Achiron, Anat
- SpringerLink (Online service)
Ähnliche Objekte (12)
Autoantigen-specific immunosuppression with tolerogenic peripheral blood cells prevents relapses in a mouse model of relapsing-remitting multiple sclerosis
Multiple Sclerosis Relapses Following Cessation of Fingolimod
Multiple sclerosis relapses are not associated with exercise
Predictors of severity and outcome of multiple sclerosis relapses
Immunoadsorption versus double-dose methylprednisolone in refractory multiple sclerosis relapses
Multiple sclerosis, fatigue and sleep disorders: beyond the clinical relapses
Quantitative benefit-risk assessment of methylprednisolone in multiple sclerosis relapses
Immunoadsorption versus double-dose methylprednisolone in refractory multiple sclerosis relapses
Correlates and trajectories of relapses in relapsing–remitting multiple sclerosis
Early postpartum treatment strategies and early postpartum relapses in women with active multiple sclerosis
Aberrant STAT phosphorylation signaling in peripheral blood mononuclear cells from multiple sclerosis patients
Neurodegeneration progresses despite complete elimination of clinical relapses in a mouse model of multiple sclerosis
Autoantigen-specific immunosuppression with tolerogenic peripheral blood cells prevents relapses in a mouse model of relapsing-remitting multiple sclerosis
Multiple Sclerosis Relapses Following Cessation of Fingolimod
Multiple sclerosis relapses are not associated with exercise
Predictors of severity and outcome of multiple sclerosis relapses
Immunoadsorption versus double-dose methylprednisolone in refractory multiple sclerosis relapses
Multiple sclerosis, fatigue and sleep disorders: beyond the clinical relapses
Quantitative benefit-risk assessment of methylprednisolone in multiple sclerosis relapses
Immunoadsorption versus double-dose methylprednisolone in refractory multiple sclerosis relapses
Correlates and trajectories of relapses in relapsing–remitting multiple sclerosis
Early postpartum treatment strategies and early postpartum relapses in women with active multiple sclerosis
Aberrant STAT phosphorylation signaling in peripheral blood mononuclear cells from multiple sclerosis patients
Neurodegeneration progresses despite complete elimination of clinical relapses in a mouse model of multiple sclerosis
Autoantigen-specific immunosuppression with tolerogenic peripheral blood cells prevents relapses in a mouse model of relapsing-remitting multiple sclerosis
Multiple Sclerosis Relapses Following Cessation of Fingolimod
Multiple sclerosis relapses are not associated with exercise
Predictors of severity and outcome of multiple sclerosis relapses
Immunoadsorption versus double-dose methylprednisolone in refractory multiple sclerosis relapses
Multiple sclerosis, fatigue and sleep disorders: beyond the clinical relapses
Quantitative benefit-risk assessment of methylprednisolone in multiple sclerosis relapses
Immunoadsorption versus double-dose methylprednisolone in refractory multiple sclerosis relapses
Correlates and trajectories of relapses in relapsing–remitting multiple sclerosis
Early postpartum treatment strategies and early postpartum relapses in women with active multiple sclerosis
Aberrant STAT phosphorylation signaling in peripheral blood mononuclear cells from multiple sclerosis patients